How much funding has Cerberus Therapeutics raised?

Cerberus Therapeutics has disclosed $4M raised across 1 round.

Where is Cerberus Therapeutics headquartered?

Cerberus Therapeutics is headquartered in Boston, US.

Cerberus Therapeutics

Boston, US · Founded 2020 · Delaware corporation · 7 employees on LinkedIn

Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.

Biotech Deep Tech Healthtech

Founders & leadership

Cerberus Therapeutics was founded in 2020 by Novalia Pishesha, Hidde Ploegh, Novalia Pishesha, PhD, Hidde L. Ploegh, PhD, and Harvey F. Lodish, PhD.

Novalia PisheshainCo-Founder

Hidde PloeghFounder

Novalia Pishesha, PhDCo-founder, BoD, SAB

Hidde L. Ploegh, PhDCo-Founder, SAB

Harvey F. Lodish, PhDCo-Founder, BoD

Xiaohong SangNamed on SEC filing

Xiaowei JinNamed on SEC filing

Harvey LodishFounder

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 round · 2021

▶$4MraisedJan 2022 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Xiaohong SangExecutive Officer
Xiaowei JinDirector
Harvey LodishDirector
Novalia PisheshaExecutive Officer, Director

Offering amount: $5M
Amount sold: $4M
First sale: Dec 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Cerberus Ventures6 shared keywordsCerberus is a multi-platform investment firm that manages capital across diverse asset classes including direct lending, private equity, real estate, credit, and venture capital. The company serves institutional investors and business partners globally through its integrated investment platforms.

Companies competing with Cerberus Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cerberus Therapeutics do?: Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.
Who founded Cerberus Therapeutics?: Cerberus Therapeutics was founded by Novalia Pishesha, Hidde Ploegh, Novalia Pishesha, PhD, Hidde L. Ploegh, PhD, Harvey F. Lodish, PhD in 2020.
How much funding has Cerberus Therapeutics raised?: Cerberus Therapeutics has disclosed $4M raised across 1 round.
Where is Cerberus Therapeutics headquartered?: Cerberus Therapeutics is headquartered in Boston, US.